Ona Therapeutics, S.L.

Novel target to treat metastatic cancer.

Spin off from IRB Barcelona based on the research conducted by Dr. Aznar-Benitah in the field of lipid metabolism. Developing a drug targeting metastasis-initiating cells for the treatment of metastatic cancer, a clear unmet clinical need.